336P PI3K pathway biomarkers and clinical response in a phase I/Ib study of GDC-0077 in hormone receptor-positive/HER2-negative breast cancer (HR+/HER2– BC) V. Gambardella,A. Cervantes,P.L. Bedard, E.P. Hamilton, A. Italiano,K. Jhaveri,D. Juric,K. Kalinsky,I.E. Krop,M. Oliveira, C. Saura,P. Schmid,N. Turner,A. Varga, B.P. Liu, J.W. Chen, J. Aimi, S. Royer-Joo, J.L. Schutzman, K.E. HutchinsonAnnals of Oncology（2020）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
